SEC Form 4 · accession 0001127602-16-068550
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Richard Reese
Director
Period of report
Nov 28, 2016
Accepted (ET)
Nov 29, 2016 · 8:43 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 28, 2016 | M | 10,710 | $30.44 | A | 44,943 | D | |
| Common Stock | Nov 28, 2016 | S | 551 | $71.92 | D | 44,392 | D | |
| Common Stock | Nov 28, 2016 | S | 3,988 | $71.93 | D | 40,404 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $30.44 | Nov 28, 2016 | M | 10,710 | D | May 7, 2011 | May 7, 2017 | Common Stock | 10,710 | 0 | D |